Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

National Stem Cell

2005 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of stem cell therapies. The company's stem cell therapies allows the growth of contaminant-free human embryonic stem (hES) cell lines that have extensive applications therapeutics and cosmetics, enabling biotechnology, doctors and medical representatives to get therapies to cure to treat a broad array of diseases

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Acquirer
Primary Office
  • 17 State Street
  • 39th Floor
  • New York, NY 10004
  • United States

National Stem Cell Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore National Stem Cell‘s full profile, request access.

Request full access to PitchBook

National Stem Cell Executive Team (1)

Name Title Board
Seat
Contact
Info
Michael Cohen Founder and Chief Executive Officer